GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
Material
Language
Years
Subjects(RVK)
  • 1
    In: Research, Society and Development, Research, Society and Development, Vol. 9, No. 8 ( 2020-07-31), p. e737986371-
    Abstract: Objetivou-se avaliar a influência da temperatura da secagem das folhas de Bixa orellana L. nas propriedades biologicas dos óleos essenciais (OE’s) obtidos. O material vegetal foi coletado e submetido a estufa convectiva de ar em temperaturas entre 35-55 °C. Os OE's foram obtidos através de hidrodestilação. O ensaio antimicrobiano foi realizado a partir do Método de Difusão de Disco frente a Staphylococcus aureus e Escherichia coli. Para o bioensaio de toxicidade avaliou-se a letalidade dos OE’s frente a Artemia salina.  Foram observadas diferenças significativas nas propriedades dos OE's. A temperatura de 45 °C permitiu obter a ação bactericida mais eficiente frente aos microrganismos testados e a toxicidade também foi verificada para o OE obtido nesta temperatura. Este estudo conclui através das atividades analisadas que a temperatura de secagem influencia nas propriedades dos OE's e a temperatura de 45° é afirmada como a mais indicada para B. orellana em virtude do melhor desempenho das propriedades tanto no ensaio antimicrobiano quanto de toxicidade.
    Type of Medium: Online Resource
    ISSN: 2525-3409
    Language: Unknown
    Publisher: Research, Society and Development
    Publication Date: 2020
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Brazilian Applied Science Review, South Florida Publishing LLC, Vol. 7, No. 1 ( 2023-01-05), p. 21-30
    Abstract: A Síndrome de Allgrove é uma doença rara hereditária, causada por mutações no gene AAAS, que possui uma tríade clássica de sintomas caracterizada por alacrimia, acalasia e insuficiência adrenal. Além da tríade, sinais neurológicos como disfunção autonômica, microcefalia, disfunção cognitiva ou demência leve, doença do neurônio motor/amiotrofia e outros podem ser mencionados em até 70% dos casos. Nessa perspectiva, o objetivo desse trabalho é a realização de um estudo observacional e exploratório sobre os artigos publicados nos últimos 5 anos sobre associação rara entre a síndrome de allgrove e amiotrofia, uma vez que essa é uma comorbidade rara da síndrome. Dos 140 resultados obtidos na pesquisa, apenas 9 abordaram de forma objetiva sobre o tema, sendo utilizados na confecção do estudo. Segundo a literatura, a amiotrofia é uma comorbidade rara da síndrome de Allgrove, que possui grande relevância devido ao seu curso rápido e progressivo.
    Type of Medium: Online Resource
    ISSN: 2595-3621 , 2595-3621
    Language: Unknown
    Publisher: South Florida Publishing LLC
    Publication Date: 2023
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Brazilian Journal of Development, South Florida Publishing LLC, Vol. 9, No. 05 ( 2023-05-23), p. 17403-17414
    Abstract: Introdução: esta pesquisa parte da necessidade de discutir sobre o perfil epidemiológico da Gastrosquise, na cidade de Teresina-PI, por se tratar de um debate extremamente importante, uma vez que impacta as esferas sociais, biológicas e psíquicas, que torna-se relevante para a saúde pública da população. Objetivo: analisar o perfil epidemiológico dos pacientes com Gastrosquise operados em uma Maternidade Pública de Referência do Estado do Piauí de 2019 a 2021. Métodos: trata-se de um estudo observacional, descritivo, quantitativo, de natureza documental. Foram coletados 30 prontuários físicos de uma Maternidade Pública do Estado, situada em Teresina-PI, com o intuito de analisar os dados através de questões norteadoras, a fim de explorar as informações presentes nos prontuários, o que levou a interpretação e discussão dos achados. Resultados: identificou-se 30 pacientes portadores de gastrosquise, no período de janeiro de 2019 a dezembro de 2021, em que 73,3% das mães realizaram o pré-natal, idade materna com média de 21 anos, 63,3% realizaram parto cesárea. Os fatores de risco relacionados ao óbito do recém-nascido incluem, o Apgar baixo, a prematuridade e o diagnóstico tardio. Conclusão: o presente estudo permitiu esclarecer sobre o perfil clínico-epidemiológico dos recém-nascidos admitidos na Maternidade Pública do Estado, situada em Teresina, Piauí, no período de janeiro de 2019 a dezembro de 2021, que reflete a necessidade de um diagnóstico no pré-natal e melhores cuidados na conduta do paciente, a fim de reduzir a mortalidade.
    Type of Medium: Online Resource
    ISSN: 2525-8761
    Language: Unknown
    Publisher: South Florida Publishing LLC
    Publication Date: 2023
    detail.hit.zdb_id: 2873644-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Cuadernos de Educación y Desarrollo, South Florida Publishing LLC, Vol. 15, No. 6 ( 2023-07-19), p. 4855-4867
    Abstract: Introdução: Educação em saúde é repleta de desafios, especialmente no processo de aprendizagem. O uso das metodologias ativas contribui na formação de profissionais de saúde críticos e reflexivos. Metodologia: Este trabalho descreve a aplicação de metodologias ativas e tradicionais na monitoria, com foco em uma metodologia baseada em projetos com o objetivo de uma cartilha com informações atualizadas sobre diferentes temas em saúde. Utilizou-se a metodologia baseada em projetos, desafiando os estudantes a praticar a criatividade e estimulando a participassem de todo o processo de desenvolvimento da cartilha. O processo envolveu pesquisa, seleção de conteúdo, design e produção colaborativa do material. Resultados: Essa abordagem proporcionou aos estudantes uma experiência prática de educação em saúde, aplicando os conhecimentos teóricos de forma concreta. A metodologia baseada em projetos estimulou a aquisição de competências essenciais, incluindo o trabalho em equipe, a organização e a habilidade de se comunicar. A cartilha resultante foi clara, acessível e atrativa, fornecendo informações úteis à comunidade. A divulgação das informações e a promoção de práticas saudáveis foram alcançadas. Conclusão: A metodologia baseada em projetos, especialmente a criação da cartilha, mostrou-se eficaz para estimular o aprendizado e o envolvimento dos estudantes. Essa abordagem proporcionou uma experiência enriquecedora, permitindo que os estudantes aplicassem seus conhecimentos, habilidades e criatividade na criação de um material educativo de qualidade.
    Type of Medium: Online Resource
    ISSN: 1989-4155 , 1989-4155
    Language: Unknown
    Publisher: South Florida Publishing LLC
    Publication Date: 2023
    detail.hit.zdb_id: 2544596-0
    detail.hit.zdb_id: 2740425-0
    SSG: 5,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: npj Precision Oncology, Springer Science and Business Media LLC, Vol. 7, No. 1 ( 2023-06-10)
    Abstract: Routine tumor-node-metastasis (TNM) staging of colorectal cancer is imperfect in predicting survival due to tumor pathobiological heterogeneity and imprecise assessment of tumor spread. We leveraged Bayesian additive regression trees (BART), a statistical learning technique, to comprehensively analyze patient-specific tumor characteristics for the improvement of prognostic prediction. Of 75 clinicopathologic, immune, microbial, and genomic variables in 815 stage II–III patients within two U.S.-wide prospective cohort studies, the BART risk model identified seven stable survival predictors. Risk stratifications (low risk, intermediate risk, and high risk) based on model-predicted survival were statistically significant (hazard ratios 0.19–0.45, vs. higher risk; P   〈  0.0001) and could be externally validated using The Cancer Genome Atlas (TCGA) data ( P  = 0.0004). BART demonstrated model flexibility, interpretability, and comparable or superior performance to other machine-learning models. Integrated bioinformatic analyses using BART with tumor-specific factors can robustly stratify colorectal cancer patients into prognostic groups and be readily applied to clinical oncology practice.
    Type of Medium: Online Resource
    ISSN: 2397-768X
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2023
    detail.hit.zdb_id: 2891458-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    In: Cancer Immunology, Immunotherapy, Springer Science and Business Media LLC, Vol. 71, No. 4 ( 2022-04), p. 933-942
    Type of Medium: Online Resource
    ISSN: 0340-7004 , 1432-0851
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2022
    detail.hit.zdb_id: 1458489-X
    detail.hit.zdb_id: 195342-4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 83, No. 7_Supplement ( 2023-04-04), p. 3014-3014
    Abstract: Background: Germline genetic factors central to immunity, such as human leukocyte antigen (HLA) variants, have been associated with several immune-related phenotypes such as response to immune checkpoint inhibitors. However, HLA and killer-cell immunoglobulin-like (KIR) gene combinations, which may modulate immune function, have not been studied in relation to T-cell density in cancer. Methods: This study was conducted within 3 well characterized epidemiologic studies that collected colorectal tumor tissue blocks (N=484). We profiled the in-situ T cell landscape of CRC using digital imaging, machine learning, and a customized 9-plex multiplexed immunofluorescence panel with antibodies directed against CD3, CD4, CD8, CD45RA, CD45RO, FOXP3, and MKI67. HLA and KIR variants were imputed from genome-wide array datasets through SNP2HLA and KIR*IMP methods. We used multivariable ordinal logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association between HLA-KIR activation/inhibition ligand combinations with quartile of T cell densities in CRC adjusting for age, sex, GWAS panel, and the first two principal components of ancestry. Results: Presence of KIR2DL2+HLAC1+ and KIR2DS2+HLAC1+ combinations were associated with lower odds of greater CD3+CD8+ T-cell density quartile, however these findings were not statistically significant [OR = 0.73, 95% CI (0.52, 1.02), p-value = 0.067; OR = 0.74 95% CI (0.53, 1.04), p-value= 0.082, respectively]. There was no association between HLA-KIR combinations and CD3+CD4+ T-cell density quartile. Further results will examine HLA and KIR genes individually, as well as additional combination variables and more specific T-cell density subsets. Conclusions: Further investigation is needed to determine if germline genetics related to immune profile plays a role in T-cell densities in CRC. Citation Format: Claire Elizabeth Thomas, Jeroen Huyghe, Tomotaka Ugai, Hang Yin, Yasutoshi Takashima, Daniel D. Buchanan, Conghui Qu, Li Hsu, Andressa Dias Costa, Stephen Gallinger, Robert Grant, Sushma Thomas, Shuji Ogino, Amanda I. Phipps, Jonathan Nowak, Ulrike Peters. Association between HLA-KIR allele interaction combinations and density of T-cell subsets in colorectal cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 3014.
    Type of Medium: Online Resource
    ISSN: 1538-7445
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2023
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    In: Clinical Cancer Research, American Association for Cancer Research (AACR), Vol. 26, No. 16 ( 2020-08-15), p. 4326-4338
    Abstract: Although high T-cell density is a well-established favorable prognostic factor in colorectal cancer, the prognostic significance of tumor-associated plasma cells, neutrophils, and eosinophils is less well-defined. Experimental Design: We computationally processed digital images of hematoxylin and eosin (H & E)–stained sections to identify lymphocytes, plasma cells, neutrophils, and eosinophils in tumor intraepithelial and stromal areas of 934 colorectal cancers in two prospective cohort studies. Multivariable Cox proportional hazards regression was used to compute mortality HR according to cell density quartiles. The spatial patterns of immune cell infiltration were studied using the GTumor:Immune cell function, which estimates the likelihood of any tumor cell in a sample having at least one neighboring immune cell of the specified type within a certain radius. Validation studies were performed on an independent cohort of 570 colorectal cancers. Results: Immune cell densities measured by the automated classifier demonstrated high correlation with densities both from manual counts and those obtained from an independently trained automated classifier (Spearman's ρ 0.71–0.96). High densities of stromal lymphocytes and eosinophils were associated with better cancer-specific survival [Ptrend & lt; 0.001; multivariable HR (4th vs 1st quartile of eosinophils), 0.49; 95% confidence interval, 0.34–0.71] . High GTumor:Lymphocyte area under the curve (AUC0,20μm; Ptrend = 0.002) and high GTumor:Eosinophil AUC0,20μm (Ptrend & lt; 0.001) also showed associations with better cancer-specific survival. High stromal eosinophil density was also associated with better cancer-specific survival in the validation cohort (Ptrend & lt; 0.001). Conclusions: These findings highlight the potential for machine learning assessment of H & E-stained sections to provide robust, quantitative tumor-immune biomarkers for precision medicine.
    Type of Medium: Online Resource
    ISSN: 1078-0432 , 1557-3265
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2020
    detail.hit.zdb_id: 1225457-5
    detail.hit.zdb_id: 2036787-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 82, No. 12_Supplement ( 2022-06-15), p. 684-684
    Abstract: Abstract Background: Biological evidence indicates that obesity influences immune responses, interacting with various immune cell populations via obesity-related systemic inflammation. We hypothesized that the association of obesity with colorectal cancer (CRC) incidence differed by T-cell, macrophage, and other myeloid cell infiltrates in tumor tissue. Methods: We developed multiplexed immunofluorescence assays to identify immune cells, including T-cell (CD3, CD4, CD8, CD45RO, and FOXP3), macrophage [CD68, CD86, IRF5, MAF, and MRC1 (CD206)], and myeloid cell (CD14, CD15, HLA-DR, ARG) subsets in tumor. Utilizing the Nurses’ Health Study (NHS) and the Health Professionals Follow-up Study (HPFS), we examined the association of body mass index (BMI) with incidence of CRC subtypes classified by each immune cell subset. We applied inverse probability-weighted Cox proportional hazards models to control for selection bias and potential confounders. We used the stringent α level of 0.005 due to multiple comparisons. Results: During follow-up of 131,144 participants (3,648,371 person-years), we documented 3,203 incident CRC cases including 886 CRC cases with available data on immune cell densities in tumor tissue. The association of cumulative average BMI (from baseline to the most recent questionnaire cycle) with CRC incidence differed by CD15+CD33- cell (mature granulocyte) densities in tumor intraepithelial regions (Phet=0.004). Cumulative average BMI was associated with incidence of tumors with low CD15+CD33- cell densities [18.5-22.5 kg/m2: reference; 22.5-24.9 kg/m2: HR (95% CI), 1.67 (1.12-2.48); 25.0-27.5 kg/m2: 1.73 (1.14-2.61); 27.5-29.9 kg/m2: 2.06 (1.32-3.21); ≥30 kg/m2: HR, 2.26 (1.45-3.52), Ptrend & lt;0.001], but not with incidence of tumors with intermediate or high CD15+CD33- cell densities (Ptrend & gt;0.049, with the α level of 0.005). The association of young adult BMI (at age 18 for NHS and at age 21 for HPFS) with CRC incidence differed by CD15+CD33+ cell [granulocytic myeloid-derived suppressor cell (MDSC)-like phenotype] densities in tumor intraepithelial regions (Phet & lt;0.001). Young adult BMI was associated with incidence of tumors with low CD15+CD33+ cell densities [18.5-22.5 kg/m2: reference; 22.5-24.9 kg/m2: HR (95% CI), 1.18 (0.96-1.44); 25.0-27.5 kg/m2: 1.44 (1.11-1.87); ≥27.5 kg/m2: 1.88 (1.35-2.62), Ptrend & lt;0.001], but the association was attenuated for tumors with intermediate and high CD15+CD33+ cell densities (Ptrend & gt;0.087). Similar differential associations were not observed in analyses of CRC subclassified by T cell or macrophage densities. Conclusions: The association of BMI with CRC incidence differed by intraepithelial myeloid cell densities. Our findings suggest an interplay of obesity from early life and granulocytic MDSCs/other granulocytes in colorectal carcinogenesis. Citation Format: Tomotaka Ugai, Juha P. Väyrynen, Yasutoshi Takashima, Seyed Mostafa Mousavi Kahaki, Benjamin Langworthy, Koichiro Haruki, Naohiko Akimoto, Mai Chan Lau, Rong Zhong, Sara A. Väyrynen, Melissa Zhao, Andressa Dias Costa, Jennifer Borowsky, Jennifer L. Guerriero, Xuehong Zhang, Andrew T. Chan, Molin Wang, Marios Giannakis, Jeffrey A. Meyerhardt, Edward L. Giovannucci, Jonathan A. Nowak, Shuji Ogino. Body mass index throughout adulthood and incidence of colorectal cancer subclassified by T cell, macrophage, and myeloid cell infiltrates in cancer tissue [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 684.
    Type of Medium: Online Resource
    ISSN: 1538-7445
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2022
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 82, No. 22_Supplement ( 2022-11-15), p. PR005-PR005
    Abstract: In preclinical work, the inflammatory cytokine IL-1β was shown to be upregulated in pancreatic cancer tumors and to contribute to activation of pancreatic stellate cells and immunosuppression (Das et al 2020). We conducted an open-label multicenter Phase Ib study evaluating gemcitabine, nab-paclitaxel, canakinumab (ACZ885), a high-affinity human anti-interleukin-1β (IL-1β) mAb, and spartalizumab (PDR001), a PD-1 mAb. Eligible subjects had previously untreated metastatic PDA and RECIST measurable disease. The primary objective was to confirm recommended phase II dose by evaluating the incidence of dose limiting toxicities (DLTs) in the first 56 days of dosing in at least 6 evaluable subjects utilizing a Bayesian logistic regression model. Subjects underwent baseline and on-study tissue and blood collection for correlative translational research. Results: 10 subjects were enrolled between Nov 2020 and Mar 2021. At the primary data cut off of May 23, 2021, 6 subjects were evaluable for DLT. There were no DLTs, the recommended Phase II dose was established as: gemcitabine (1000mg/m2 IV) day 1,8,15; nab-paclitaxel (125mg/m2 IV) day 1,8,15; canakinumab (250mg SC) day 1, spartalizumab (400mg IV) day 1; of each 28 day cycle. At the time of an updated database extraction on June 1, 2022, 2 subjects remain on study. Adverse events were consistent with those typically seen with chemotherapy. The most common Grade 3/4 AEs were neutropenia (60%) and anemia (50%), with no fatal AEs. One patient discontinued spartalizumab due to grade 3 pneumonitis. In preliminary efficacy analysis (n=10), there are 3 confirmed PRs, 5 subjects with stable disease, 2 subjects with progression as best response. Individual site data estimates that the 12 month OS rate is 60%; updated RR, PFS and OS data will be reported. Activation of CD8 T cells in peripheral blood and increased serum levels of IFN-induced chemokines CXCL9/10 were observed in both responder and non-responder patients. Using an in vitro suppression assay, we showed that baseline serum from responders could induce myeloid derived suppressor cells, an effect that was abrogated with treatment. Single cell transcriptional profiling, multiplex immunofluorescence and spatial transcriptomics also revealed treatment-dependent shifts in T cell activation state and myeloid cells in the tumors of patients experiencing clinical response. Conclusions: PanCAN-SR1 established the Phase II dose of canakinumab and spartalizumab with chemotherapy in first line metastatic PDA, based upon favorable benefit-risk assessment. Based on our comprehensive analysis of 10 patients treated with combination therapy including IL-1b blockade, we hypothesize that the definitive role of anti-IL-1b in human patients with pancreatic cancer is to reduce systemic immune suppression and to reduce immunosuppressive myeloid cell activation in the tumor. The clinical utility of targeting IL-1β in pancreatic cancer is being evaluated in a randomized Phase II/III study through the Precision Promise clinical trial network. NCT04581343. Citation Format: Paul E. Oberstein, Osama Rahma, Nina Beri, Amy Stoll-D'Astice, Emily A. Kawaler, Igor Dolgalev, Gregor Werba, Victoire Cardo-Ruffino, Naïma Böllenrücher, Andressa Dias Costa, Saloney Nazeer, Matthew Squires, Jonathan Nowak, Dafna Bar-Sagi, Brian Wolpin, Diane M Simeone, Stephanie K Dougan. Primary results of PanCAN-SR1, a phase 1b study evaluating Gemcitabine, nab-Paclitaxel, Canakinumab, and Spartalizumab to target IL-1β and PD-1 in metastatic pancreatic cancer with correlative tissue and blood biomarker analysis [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic Cancer; 2022 Sep 13-16; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2022;82(22 Suppl):Abstract nr PR005.
    Type of Medium: Online Resource
    ISSN: 1538-7445
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2022
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...